The Odontogenic Tumor Market forecast anticipates significant, albeit measured, growth, heavily influenced by breakthroughs in molecular and genetic understanding of tumor pathogenesis. The future trajectory is moving beyond surgical excision as the sole treatment, incorporating targeted molecular therapies for aggressive or recurrent lesions, such as certain Ameloblastomas which harbor...